334 related articles for article (PubMed ID: 30424716)
1. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
Durojaiye I; Akinbami A; Dosunmu A; Ajibola S; Adediran A; Uche E; Oshinaike O; Odesanya M; Dada A; Okunoye O
Pan Afr Med J; 2014; 17():301. PubMed ID: 25328597
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
9. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.
Chang L; Ou S; Shan Z; Zhu F; Ji H; Rong X; Guo F; Jiang X; Sun H; Yan Y; Wang L
Retrovirology; 2021 Jan; 18(1):2. PubMed ID: 33413457
[TBL] [Abstract][Full Text] [Related]
12. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
13. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
[TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.
Carneiro-Proietti AB; Sabino EC; Leão S; Salles NA; Loureiro P; Sarr M; Wright D; Busch M; Proietti FA; Murphy EL;
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1265-72. PubMed ID: 22324906
[TBL] [Abstract][Full Text] [Related]
16. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
17. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
Dalekos GN; Zervou E; Karabini F; Elisaf M; Bourantas K; Siamopoulos KC
Transfusion; 1995 Jun; 35(6):503-6. PubMed ID: 7770902
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.
Chandía L; Sotomayor C; Ordenes S; Salas P; Navarrete M; Lopez M; Otth C
Med Microbiol Immunol; 2010 Nov; 199(4):341-4. PubMed ID: 20706847
[TBL] [Abstract][Full Text] [Related]
20. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]